JP2021522262A5 - - Google Patents

Info

Publication number
JP2021522262A5
JP2021522262A5 JP2020560186A JP2020560186A JP2021522262A5 JP 2021522262 A5 JP2021522262 A5 JP 2021522262A5 JP 2020560186 A JP2020560186 A JP 2020560186A JP 2020560186 A JP2020560186 A JP 2020560186A JP 2021522262 A5 JP2021522262 A5 JP 2021522262A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
group
heteroaryl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020560186A
Other languages
English (en)
Japanese (ja)
Other versions
JP7351851B2 (ja
JP2021522262A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/030526 external-priority patent/WO2019213470A1/en
Publication of JP2021522262A publication Critical patent/JP2021522262A/ja
Publication of JP2021522262A5 publication Critical patent/JP2021522262A5/ja
Application granted granted Critical
Publication of JP7351851B2 publication Critical patent/JP7351851B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020560186A 2018-05-03 2019-05-03 レチノイド関連オルファン受容体ガンマ(RORγ)のモジュレーターとしてのベンジイミダゾール誘導体およびそれらの医薬品用途 Active JP7351851B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862666312P 2018-05-03 2018-05-03
US62/666,312 2018-05-03
PCT/US2019/030526 WO2019213470A1 (en) 2018-05-03 2019-05-03 Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (rorϒ) and pharmaceutical uses thereof

Publications (3)

Publication Number Publication Date
JP2021522262A JP2021522262A (ja) 2021-08-30
JP2021522262A5 true JP2021522262A5 (enExample) 2022-05-12
JP7351851B2 JP7351851B2 (ja) 2023-09-27

Family

ID=68386171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020560186A Active JP7351851B2 (ja) 2018-05-03 2019-05-03 レチノイド関連オルファン受容体ガンマ(RORγ)のモジュレーターとしてのベンジイミダゾール誘導体およびそれらの医薬品用途

Country Status (19)

Country Link
US (2) US11512055B2 (enExample)
EP (1) EP3781161B1 (enExample)
JP (1) JP7351851B2 (enExample)
KR (1) KR102709804B1 (enExample)
CN (2) CN116514722A (enExample)
AU (1) AU2019262169B2 (enExample)
BR (1) BR112020021967A2 (enExample)
CA (1) CA3097519A1 (enExample)
ES (1) ES2949366T3 (enExample)
HR (1) HRP20230643T1 (enExample)
HU (1) HUE062273T2 (enExample)
MX (1) MX2020011405A (enExample)
MY (1) MY208400A (enExample)
PL (1) PL3781161T3 (enExample)
RS (1) RS64348B1 (enExample)
SM (1) SMT202300212T1 (enExample)
TW (1) TWI818985B (enExample)
UA (1) UA128161C2 (enExample)
WO (1) WO2019213470A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102709804B1 (ko) * 2018-05-03 2024-09-25 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 레티노이드-관련 희귀 수용체 감마(RORγ)의 조절제로서 벤즈이미다졸 유도체 및 이의 약학적 용도
KR20220093340A (ko) * 2019-10-31 2022-07-05 지앙수 헨그루이 메디슨 컴퍼니 리미티드 RORγ 조절제의 산부가염
CN112745268B (zh) * 2019-10-31 2022-09-16 江苏恒瑞医药股份有限公司 苯并咪唑衍生物的晶型及制备方法
TW202136238A (zh) * 2020-01-06 2021-10-01 大陸商廣東東陽光藥業有限公司 RORγt抑制劑及其製備方法和用途
TW202136237A (zh) * 2020-01-06 2021-10-01 大陸商廣東東陽光藥業有限公司 RORγt抑制劑及其製備方法和用途
CN111269126B (zh) * 2020-03-12 2023-04-07 北京理工大学重庆创新中心 一种熔铸载体1,2-二氟-4,5-二硝基苯的制备方法
WO2021204801A1 (en) * 2020-04-07 2021-10-14 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
TW202146381A (zh) * 2020-05-15 2021-12-16 大陸商上海輝启生物醫藥科技有限公司 可用作RORγ調節劑的聯芳基類化合物
WO2022245067A1 (ko) * 2021-05-17 2022-11-24 서울대학교 산학협력단 RORα의 활성자 JC1-40을 포함하는 근감소증 예방, 개선, 또는 치료를 위한 약학적 조성물
CN121045325A (zh) * 2024-05-31 2025-12-02 中国科学院广州生物医药与健康研究院 磺酰胺基乙酰胺类化合物及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3075991A (en) * 1960-01-20 1963-01-29 Dow Chemical Co Benzimidazolylalkylbenzene-sulfonamide compounds
WO2001016097A1 (en) * 1999-08-27 2001-03-08 Sugen, Inc. Phosphate mimics and methods of treatment using phosphatase inhibitors
US7951829B2 (en) * 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1
JP5892550B2 (ja) * 2010-05-24 2016-03-23 トーアエイヨー株式会社 縮合イミダゾール誘導体
WO2012027965A1 (en) 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
CN102060780B (zh) 2010-12-27 2014-11-05 雅本化学股份有限公司 2-(n-取代)-氨基苯并咪唑衍生物的制备方法
WO2013029338A1 (en) 2011-09-01 2013-03-07 Glaxo Group Limited Novel compounds
BR112014030940B1 (pt) * 2012-06-11 2022-09-06 UCB Biopharma SRL Benzimidazóis que modulam tnf-alfa e composição farmacêutica compreendendo os mesmos
CN105849090A (zh) * 2013-10-30 2016-08-10 诺华股份有限公司 2-苄基-苯并咪唑补体因子b抑制剂及其用途
NZ723530A (en) 2014-04-14 2023-05-26 Boehringer Ingelheim Int Compounds as modulators of ror gamma
SG11201607518RA (en) * 2014-04-16 2016-10-28 Glenmark Pharmaceuticals Sa Aryl and heteroaryl ether compounds as ror gamma modulators
WO2015196335A1 (en) * 2014-06-23 2015-12-30 Tocopherx, Inc. Pyrazole compounds as modulators of fshr and uses thereof
EP3172197A4 (en) * 2014-07-25 2018-03-14 Innov17 LLC Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof
FR3030516B1 (fr) * 2014-12-19 2019-12-27 Galderma Research & Development Derives sulfonamides bicycles en tant qu'agonistes inverses du recepteur gamma orphelin associe aux retinoides ror gamma (t)
TWI757266B (zh) * 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
KR102709804B1 (ko) * 2018-05-03 2024-09-25 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 레티노이드-관련 희귀 수용체 감마(RORγ)의 조절제로서 벤즈이미다졸 유도체 및 이의 약학적 용도

Similar Documents

Publication Publication Date Title
JP2021522262A5 (enExample)
JP2010539166A5 (enExample)
HRP20240994T1 (hr) Spoj inhibitora jak i njegova uporaba
JP2019031560A5 (enExample)
KR102346508B1 (ko) 키나제 억제제로서 유용한 치환된 테트라히드로카르바졸 및 카르바졸 카르복스아미드 화합물
CA2651363A1 (en) Triazolopyrazine derivatives useful as anti-cancer agents
RU2015149767A (ru) Дейтерированные диаминопиримидиновые соединения и фармацевтические композиции, содержащие такие соединения
JP2011527667A5 (enExample)
KR102345381B1 (ko) 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물
KR102519536B1 (ko) 트리시클릭 회전장애이성질체 화합물
JP2016527238A5 (enExample)
JP2017515844A5 (enExample)
JP2017504576A5 (enExample)
JP2016028076A5 (enExample)
JP2018526410A5 (enExample)
JP2017508733A5 (enExample)
JP2016505058A5 (enExample)
JP2017506666A5 (enExample)
JP2006507355A5 (enExample)
JP2023518044A5 (enExample)
CA3002801A1 (en) Aminoisoxazoline compounds as agonists of alpha7-nicotinic acetylcholine receptors
JP2006519868A5 (enExample)
JP2011526911A (ja) ベンゾイミダゾール−2−イルピリミジン誘導体を製造する方法
JP2013525490A5 (enExample)
JP2015502371A5 (enExample)